Cargando…

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer

Detalles Bibliográficos
Autores principales: Yang, Yue, Zhang, Jieyun, Chen, Yanxing, Xu, Ruihua, Zhao, Qi, Guo, Weijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443139/
https://www.ncbi.nlm.nih.gov/pubmed/32898332
http://dx.doi.org/10.1002/ctm2.155
_version_ 1783573575926546432
author Yang, Yue
Zhang, Jieyun
Chen, Yanxing
Xu, Ruihua
Zhao, Qi
Guo, Weijian
author_facet Yang, Yue
Zhang, Jieyun
Chen, Yanxing
Xu, Ruihua
Zhao, Qi
Guo, Weijian
author_sort Yang, Yue
collection PubMed
description
format Online
Article
Text
id pubmed-7443139
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74431392020-08-28 MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer Yang, Yue Zhang, Jieyun Chen, Yanxing Xu, Ruihua Zhao, Qi Guo, Weijian Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-08-22 /pmc/articles/PMC7443139/ /pubmed/32898332 http://dx.doi.org/10.1002/ctm2.155 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Yang, Yue
Zhang, Jieyun
Chen, Yanxing
Xu, Ruihua
Zhao, Qi
Guo, Weijian
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title_full MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title_fullStr MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title_full_unstemmed MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title_short MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
title_sort muc4, muc16, and ttn genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443139/
https://www.ncbi.nlm.nih.gov/pubmed/32898332
http://dx.doi.org/10.1002/ctm2.155
work_keys_str_mv AT yangyue muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer
AT zhangjieyun muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer
AT chenyanxing muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer
AT xuruihua muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer
AT zhaoqi muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer
AT guoweijian muc4muc16andttngenesmutationcorrelatedwithprognosisandpredictedtumormutationburdenandimmunotherapyefficacyingastriccancerandpancancer